Abbott Laboratories 

R$44
3933
+R$0.26+0.59% Tuesday 18:54

Statistics

Day High
44.2
Day Low
43.51
52W High
65.52
52W Low
43.51
Volume
68
Avg. Volume
846
Mkt Cap
76.46B
P/E Ratio
25.05
Dividend Yield
29.51%
Dividend
12.98

Upcoming

Dividends

29.51%Dividend Yield
Feb 26
R$3.38
Nov 25
R$3.21
Aug 25
R$3.28
May 25
R$3.47
Feb 25
R$3.54
10Y Growth
9.25%
5Y Growth
6.96%
3Y Growth
7.3%
1Y Growth
6.78%

Earnings

16AprExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
1.07
1.21
1.36
1.5
Expected EPS
1.148662
Actual EPS
N/A

Financials

14.71%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
487.61BRevenue
71.72BNet Income

Analyst Ratings

$244.72Average Price Target
The highest estimate is 262.33.
From 10 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ABTT34.SA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson competes with Abbott in multiple segments including medical devices, diagnostics, and pharmaceuticals, making it a direct competitor across several of Abbott's business lines.
Medtronic
MDT
Mkt Cap111.22B
Medtronic competes with Abbott in the medical devices sector, particularly in cardiovascular and diabetes care products.
Thermo Fisher Scientific
TMO
Mkt Cap182.57B
Thermo Fisher Scientific competes with Abbott in the diagnostics and life sciences sector, offering a range of analytical instruments, reagents, and consumables.
Danaher
DHR
Mkt Cap135.26B
Danaher Corporation competes with Abbott in the diagnostics and life sciences industry, particularly through its subsidiary Cepheid, which offers molecular diagnostics solutions.
Boston Scientific
BSX
Mkt Cap93.36B
Boston Scientific competes with Abbott in the medical devices sector, especially in cardiovascular products.
Baxter International
BAX
Mkt Cap8.61B
Baxter International competes with Abbott in the medical devices and nutrition sectors, offering products for critical care, nutrition, renal care, and more.
Stryker
SYK
Mkt Cap126.97B
Stryker competes with Abbott in the medical devices sector, particularly in orthopedics, which indirectly competes with Abbott's offerings in other medical device categories.
Becton Dickinson
BDX
Mkt Cap55.98B
Becton, Dickinson and Company competes with Abbott in the medical technology sector, offering devices, laboratory equipment, and diagnostic products.
Resmed
RMD
Mkt Cap32.71B
ResMed competes with Abbott in the health sector by providing medical devices for sleep disorders and respiratory conditions, which complements Abbott's broader medical device portfolio.
Hologic
HOLX
Mkt Cap16.89B
Hologic competes with Abbott in the diagnostics sector, particularly in women's health, where both companies offer a range of diagnostic and medical imaging solutions.

About

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Show more...
CEO
Mr. Robert B. Ford
Employees
113000
Country
United States
ISIN
BRABTTBDR007

Listings

0 Comments

Share your thoughts

FAQ

What is Abbott Laboratories stock price today?
The current price of ABTT34.SA is R$44 BRL — it has increased by +0.59% in the past 24 hours. Watch Abbott Laboratories stock price performance more closely on the chart.
What is Abbott Laboratories stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Abbott Laboratories stocks are traded under the ticker ABTT34.SA.
Is Abbott Laboratories stock price growing?
ABTT34.SA stock has fallen by -0.56% compared to the previous week, the month change is a -6.38% fall, over the last year Abbott Laboratories has showed a -27.96% decrease.
What is Abbott Laboratories market cap?
Today Abbott Laboratories has the market capitalization of 76.46B
When is the next Abbott Laboratories earnings date?
Abbott Laboratories is going to release the next earnings report on April 16, 2026.
What were Abbott Laboratories earnings last quarter?
ABTT34.SA earnings for the last quarter are 7.93 BRL per share, whereas the estimation was 7.9 BRL resulting in a +0.29% surprise. The estimated earnings for the next quarter are N/A BRL per share.
What is Abbott Laboratories revenue for the last year?
Abbott Laboratories revenue for the last year amounts to 487.61B BRL.
What is Abbott Laboratories net income for the last year?
ABTT34.SA net income for the last year is 71.72B BRL.
Does Abbott Laboratories pay dividends?
Yes, ABTT34.SA dividends are paid quarterly. The last dividend per share was 0.19 BRL. As of today, Dividend Yield (FWD)% is 29.51%.
How many employees does Abbott Laboratories have?
As of April 08, 2026, the company has 113,000 employees.
In which sector is Abbott Laboratories located?
Abbott Laboratories operates in the Healthcare sector.
When did Abbott Laboratories complete a stock split?
The last stock split for Abbott Laboratories was on November 21, 2022 with a ratio of 3:1.
Where is Abbott Laboratories headquartered?
Abbott Laboratories is headquartered in North Chicago, United States.